Differences

This shows you the differences between two versions of the page.

--- home:othertreatments:hypoglycemics [05.25.2009] – paulalbert
+++ home:othertreatments:hypoglycemics [01.03.2012] – external edit 127.0.0.1
@@ Line 1: / Line 1: @@
+====== Hypoglycemics    ======
+<relatedarticle> [[home:patients:assessing_literature:palliative|Palliative vs. curative treatments]] </article>
+The goal of a hypoglycemic is to lower the concentration of glucose in the blood. The action of these drugs is inconsistent with the goal of the Marshall Protocol (MP), namely to destroy the pathogenic bacteria causing glucose imbalance in the first place.
+Hypoglycemics work, at least in part, by interfering with immune function. One study found that metformin artificially decreased concentrations of both interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in type 2 diabetic patients.(({{pubmed>long: 17022850}}))
+Certain adverse effects are associated with use of hyplogycemics.  For example, metformin is associated with lactic acidosis. (({{pubmed>long:17140168}}))
+===== Types of hypoglycemics =====
+  * Avandamet (contains rosiglitazone)
+  * exenatide (Byetta)
+  * nateglinide (Starlix)
+  * pioglitazone (Actos)
+  * metformin (Diabex, Glucophage, Glumetza, Ratio-Metformin)
+  * rosiglitazone (Avandia)
+{{tag>non-MP_therapies}}
+===== Notes and comments =====
+  * Legacy content
+    *
+===== References =====

home/othertreatments/hypoglycemics.txt · Last modified: 09.14.2022 by 127.0.0.1